About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Dallas | 13,698 Studies Near You

Clinical TrialsDallas

Clinical Trials in Dallas

Discover 13,698 clinical trials near Dallas, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1261-1280 of 13,698 trials

CompletedA Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3To evaluate the anti-HIV activity, safety, and tolerance of adefovir dipivoxil ( bis-POM PMEA ) in combination with standard antiretroviral therapy for 48 weeks.NCT00002161·Birmingham, Alabama and 26 others TerminatedControlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic PatientsThis 12-week clinical study evaluates the safety and efficacy of Albuterol Sulfate HFA Inhalation Aerosol (Albuterol-HFA, or: A004), Armstrong's proposed HFA formulation of…NCT00635505·Mobile, Alabama and 41 others

Find Trials by Condition in Dallas

Breast Cancerin Dallas Lung Cancerin Dallas Prostate Cancerin Dallas Colorectal Cancerin Dallas Melanomain Dallas Leukemiain Dallas Lymphomain Dallas Pancreatic Cancerin Dallas Ovarian Cancerin Dallas Brain Cancerin Dallas Diabetesin Dallas

Data from ClinicalTrials.govTerms

CompletedEffects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44The core study assessed the efficacy of a higher dose of rivastigmine 13.3 mg/24 h transdermally (15 cm\^2 patch) compared to a lower dose of the rivastigmine 4.6 mg/24 h…NCT00948766·Tempe, Arizona and 94 others

CompletedThe RELAX Trial: Nonpharmaceutical Intervention for Nocturnal Muscle CrampsThe purpose of the study is to learn about reducing the symptoms and severity of nighttime lower body muscle cramps in patients with and without cirrhosis.NCT05457322·Los Angeles, California and 5 others

TerminatedMitochondrial Function in Patients With Severe Liver DiseaseThe researchers will recruit patients with liver disease at Parkland Hospital.NCT02457702·Dallas, Texas

TerminatedHydroCoil Cerebral Aneurysm Treatment TrialThe study will compare clinical and angiographic outcomes in patients receiving Hydrocoil aneurysm treatment versus patients receiving non-HydroCoil aneurysm treatment.NCT01195129·Carmichael, California and 10 others

CompletedPeer Support For Young Adult Women With High Breast Cancer RiskThis trial will recruit young adult female relatives (YARs) of male or female carriers of BRCA1/2.NCT04248257·Washington D.C., District of Columbia and 5 others

TerminatedPacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and ThrombocytopeniaPhase 3, randomized, controlled study to evaluate the safety and efficacy of oral pacritinib compared to Best Available Therapy (BAT) in patients with thrombocytopenia and primary…NCT02055781·Scottsdale, Arizona and 121 others

RecruitingA Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseaseCrohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut.NCT06233461·Murrieta, California and 200 others

TerminatedA Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic PainThe purpose of this study is to determine the safety and minimum effective dose of intraspinal gabapentin when delivered through an implanted drug infusion system.NCT00414466·Little Rock, Arkansas and 13 others

CompletedEfficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 DiabetesThis trial is conducted in Asia, Europe and North America.NCT01819129·Glendale, Arizona and 143 others

WithdrawnStudy of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)This is a Phase 1/2, multicenter, open-label study to evaluate the efficacy, and safety of various combinations with selinexor in participants with RR DLBCL.NCT04607772·Tucson, Arizona and 17 others

CompletedQuantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care UnitAntimicrobial resistance is a global health emergency estimated to be responsible for 700,000 deaths per year worldwide, and it is well known that previous antibiotic exposure is…NCT05171257·Dallas, Texas

Completedin Vitro Fertilization (IVF) Media Protein and Live Birth RatesHuman conception in vivo occurs in a complex milieu that includes proteins.NCT00708383·Dallas, Texas and 1 other

CompletedEfficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodPrimary Objective: To demonstrate the superiority of the insulin glargine/lixisenatide fixed ratio combination (FRC) versus GLP-1 receptor agonist (GLP-1 RA) in hemoglobin A1c…NCT02787551·Birmingham, Alabama and 123 others

Terminated67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory NeuroblastomaThe aim of this study is to evaluate the safety and efficacy of 67Cu-SARTATE in pediatric patients with high-risk neuroblastoma.NCT04023331·Phoenix, Arizona and 7 others

CompletedGuideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure.A multicenter, non-randomized prospective longitudinal study to evaluate the feasibility of Tricog's Remote platform for Guideline Directed Medical Therapy (GDMT) titration and…NCT05906745·Durham, North Carolina and 3 others

TerminatedA Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)The main purpose of this study is to assess the efficacy and safety of LY3540378 in adults with worsening heart failure with preserved ejection fractionNCT05592275·Tucson, Arizona and 136 others

CompletedA Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive ImpairmentThis study will evaluate the safety, tolerability, and potential effects on cognition of GRF6021, a plasma-derived product, administered as an intravenous (IV) infusion, to…NCT03713957·Little Rock, Arkansas and 28 others

CompletedELUVIA™ Drug-eluting Stent Versus Zilver® PTX® StentThe primary objective of this trial is to evaluate the safety and effectiveness of the Boston Scientific Corporation (BSC) ELUVIA Drug-Eluting Vascular Stent System (ELUVIA Stent)…NCT02574481·Yuma, Arizona and 67 others

PreviousPage 64 of 685Next

Heart Diseasein Dallas